EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Updated antimicrobial dosing recommendations for obese patients

Ana Castro-Balado iD, Iria Varela-Rey iD, Beatriz Mejuto iD, Cristina Mondelo-García iD, Irene Zarra-Ferro, Teresa Rodríguez-Jato iD, Anxo Fernández-Ferreiro iD

Antimicrobial Agents and Chemotherapy · 02.05.2024 · 68 (5)

DOI: 10.1128/aac.01719-23 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.05.2024. Verfasst von Ana Castro-Balado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Obesity. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MEC | Instituto de Salud Carlos III (ISCIII), Xunta de Galicia (Regional Government of Galicia).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of obesity has increased considerably in the last few decades. Pathophysiological changes in obese patients lead to pharmacokinetic (PK) and pharmacodynamic (PD) alterations that can condition the correct exposure to antimicrobials if standard dosages are used. Inadequate dosing in obese patients can lead to toxicity or therapeutic failure. In recent years, additional antimicrobial PK/PD data, extended infusion strategies, and studies in critically ill patients have made it possible to obtain data to provide a better dosage in obese patients. Despite this, it is usually difficult to find information on drug dosing in this population, which is sometimes contradictory. This is a comprehensive review of the dosing of different types of antimicrobials (antibiotics, antifungals, antivirals, and antituberculosis drugs) in obese patients, where the literature on PK and possible dosing strategies in obese adults was critically assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsObesityHumansAnti-Infective AgentsAntifungal AgentsAntitubercular AgentsAntiviral AgentsCritical Illness

Stichwörter der Autor:innen

antimicrobialdosingobesitypharmacodynamicspharmacokineticsweight

Substanzen

Anti-Bacterial AgentsAnti-Infective AgentsAntifungal AgentsAntitubercular AgentsAntiviral Agents

Autor:innen und Institutionen

  • Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
  • Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

ORCID-Profile: Ana Castro-Balado, Iria Varela-Rey, Beatriz Mejuto, Cristina Mondelo-García, Teresa Rodríguez-Jato, Anxo Fernández-Ferreiro

Förderung

  • MEC | Instituto de Salud Carlos III (ISCIII)
  • Xunta de Galicia (Regional Government of Galicia)

Zitieren

APA

Castro-Balado, A., Varela-Rey, I., Mejuto, B., Mondelo-García, C., Zarra-Ferro, I., Rodríguez-Jato, T., & Fernández-Ferreiro, A. (2024). Updated antimicrobial dosing recommendations for obese patients. Antimicrobial Agents and Chemotherapy, 68(5). https://doi.org/10.1128/aac.01719-23

Vancouver

Castro-Balado A, Varela-Rey I, Mejuto B, Mondelo-García C, Zarra-Ferro I, Rodríguez-Jato T, et al. Updated antimicrobial dosing recommendations for obese patients. Antimicrobial Agents and Chemotherapy. 2024;68(5). doi:10.1128/aac.01719-23

BibTeX
@article{CastroBalado2024,
  author = {Castro-Balado, Ana and Varela-Rey, Iria and Mejuto, Beatriz and Mondelo-García, Cristina and Zarra-Ferro, Irene and Rodríguez-Jato, Teresa and Fernández-Ferreiro, Anxo},
  title = {Updated antimicrobial dosing recommendations for obese patients},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {5},
  doi = {10.1128/aac.01719-23}
}
Kostenlos starten →